A drug with the SMILES CC(C)CN(C(=O)CN1C(=O)NC(c2ccccc2)(c2ccccc2)C1=O)C1CCS(=O)(=O)C1 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 4.800\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CC(C)CN(C(=O)CN1C(=O)NC(c2ccccc2)(c2ccccc2)C1=O)C1CCS(=O)(=O)C1
CC(C)CN(C(=O)CN1C(=O)NC(c2ccccc2)(c2ccccc2)C1=O)C1CCS(=O)(=O)C1
2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-(1,1-dioxothiolan-3-yl)-N-(2-methylpropyl)acetamide